258 related articles for article (PubMed ID: 29528232)
21. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
[TBL] [Abstract][Full Text] [Related]
22. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
Gao N; Wang FX; Wang G; Zhao QS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
[TBL] [Abstract][Full Text] [Related]
23. miR-592 functions as a tumor suppressor in human non-small cell lung cancer by targeting SOX9.
Li Z; Li B; Niu L; Ge L
Oncol Rep; 2017 Jan; 37(1):297-304. PubMed ID: 28004116
[TBL] [Abstract][Full Text] [Related]
24. miR-183-5p functions as a tumor suppressor in lung cancer through PIK3CA inhibition.
Meng F; Zhang L
Exp Cell Res; 2019 Jan; 374(2):315-322. PubMed ID: 30528264
[TBL] [Abstract][Full Text] [Related]
25. Effects of ebv-miR-BART7 on tumorigenicity, metastasis, and TRAIL sensitivity of non-small cell lung cancer.
Wang L; Liu LF; Zhou L; Liao F; Wang J
J Cell Biochem; 2019 Jun; 120(6):10057-10068. PubMed ID: 30569505
[TBL] [Abstract][Full Text] [Related]
26. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression.
Liu W; Xiao P; Wu H; Wang L; Kong D; Yu F
Oncol Res; 2017 Jul; 25(6):975-988. PubMed ID: 27938506
[TBL] [Abstract][Full Text] [Related]
28. miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers.
Zhou H; Huang Z; Chen X; Chen S
Biomed Pharmacother; 2017 May; 89():1453-1461. PubMed ID: 28415380
[TBL] [Abstract][Full Text] [Related]
29. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
30. Lower miR-340 expression predicts poor prognosis of non-small cell lung cancer and promotes cell proliferation by targeting CDK4.
Qin Y; Zhou X; Huang C; Li L; Liu H; Liang N; Chen Y; Ma D; Han Z; Xu X; He J; Li S
Gene; 2018 Oct; 675():278-284. PubMed ID: 29935356
[TBL] [Abstract][Full Text] [Related]
31. MiR-512-5p induces apoptosis and inhibits glycolysis by targeting p21 in non-small cell lung cancer cells.
Chu K; Gao G; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Oncol; 2016 Feb; 48(2):577-86. PubMed ID: 26648284
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-585 acts as a tumor suppressor in non-small-cell lung cancer by targeting hSMG-1.
Ding X; Yang Y; Sun Y; Xu W; Su B; Zhou X
Clin Transl Oncol; 2017 May; 19(5):546-552. PubMed ID: 27743168
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-15a induces cell apoptosis and inhibits metastasis by targeting BCL2L2 in non-small cell lung cancer.
Yang T; Thakur A; Chen T; Yang L; Lei G; Liang Y; Zhang S; Ren H; Chen M
Tumour Biol; 2015 Jun; 36(6):4357-65. PubMed ID: 25874488
[TBL] [Abstract][Full Text] [Related]
35. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer.
Li G; Wang K; Wang J; Qin S; Sun X; Ren H
J Cell Biochem; 2019 Jun; 120(6):10587-10595. PubMed ID: 30816573
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
37. MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN.
Xue X; Liu Y; Wang Y; Meng M; Wang K; Zang X; Zhao S; Sun X; Cui L; Pan L; Liu S
Oncotarget; 2016 Dec; 7(51):84508-84519. PubMed ID: 27811366
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
39. miR-186 regulates chemo-sensitivity to paclitaxel via targeting MAPT in non-small cell lung cancer (NSCLC).
Ye J; Zhang Z; Sun L; Fang Y; Xu X; Zhou G
Mol Biosyst; 2016 Oct; 12(11):3417-3424. PubMed ID: 27714074
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2.
Sun J; Tian X; Lu SQ; Hu HB
Biomed Pharmacother; 2017 Dec; 96():1358-1362. PubMed ID: 29169732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]